Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: RG's Letter. I think his followup letter was a good strategic idea.

Perhaps we're finding out with three recent licenses now that the German re-validation has carried more weight than some have thought. Remember that the German revalidation was for the entire MMP. The USPTO actions are for parts of the MMP.

You have to admit that licensing has picked up considerably since the German Revalidation. What we don't know until the next Q is if the rates have finally went up as well.

So the USPTO rejection may not be as big a deal in the overall scheme of things. So Milestone may be correct for all we know.

ALl the best,

Steve

Share
New Message
Please login to post a reply